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Abstract
Background: The ciliary neurotrophic factor (CNTF) receptor is composed of two signalling
receptor chains, gp130 and the leukaemia inhibitory factor receptor, associated with a non-
signalling CNTF binding receptor α component (CNTFR). This tripartite receptor has been shown
to play important roles in the development of motor neurons, but the identity of the relevant
ligand(s) is still not clearly established. Recently, we have identified two new ligands for the CNTF
receptor complex. These are heterodimeric cytokines composed of cardiotrophin-like cytokine
(CLC) associated either with the soluble receptor subunit cytokine-like factor-1 (CLF) or the
soluble form of the binding receptor itself (sCNTFR).
Results: Here we show that, during development, clc is expressed in lung, kidney, vibrissae, tooth,
epithelia and muscles during the period of development corresponding to when motoneuron loss
is observed in mice lacking a functional CNTF receptor. In addition, we demonstrate that it is co-
expressed at the single cell level with clf and cntfr, supporting the idea that CLC might be co-
secreted with either CLF or sCNTFR.
Conclusion: This expression pattern is in favor of CLC, associated either with CLF or sCNTFR,
being an important player in the signal triggered by the CNTF receptor being required for
motoneuron development.
Background
CLC (cardiotrophin-like cytokine) shares homology with
CNTF (ciliary neurotrophic factor) and CT-1 (cardio-
trophin-1) and requires co-expression with either CLF
(cytokine-like factor-1) or the soluble form of the CNTFR
to be secreted [1,2]. The CLC-CLF heterodimer displays
activities only on cells expressing a functional CNTF
receptor [1] and therefore CLC is likely to be part of the
developmentally important second ligand for CNTFR. The
existence of such a second ligand has been suggested by
the phenotype of mice lacking any of the three receptor
subunits comprising the functional CNTF receptor com-
plex (LIFRβ, gp130 and CNTFR) which exhibit significant
reductions in motoneuron number [3-5] whereas CNTF-
deficient mice have no motoneuron loss during develop-
ment [6]. There are however two prerequisites for CLC to
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play a major role in motoneuron development: 1) CLC
must be expressed in the environment of motoneurons
during development. 2) As it cannot be secreted alone, it
must be co-expressed with either CLF or sCNTFR, in the
same cell.
Results and Discussion
Developmental expression of clc
Since the expression of clc has only been studied in adult
mouse tissues [7], we first examined the expression of
genes encoding CLC or its co-secreted proteins, CLF and
CNTFR in various embryonic tissues using reverse tran-
scription and quantitative real-time polymerase chain
reaction (RT-PCR). In all tissues tested from E16.5 and
E18.5 (Table 1), the level of expression of clc is very low
when compared with that of clf or cntfr. The highest level
of clc expression was observed in the muzzle, a very heter-
ogeneous region containing different positive tissues, as
described below. Clc expression is also observed in lung,
kidney, brain and skeletal muscles such as the tongue or
limb muscles.
To further assess the potential involvement of CLC in the
development of motoneurons, we performed in situ
hybridization experiments to determine the pattern of
expression of clc in the environment of developing
motoneurons and compare it with the expression of both
clf and cntfr. Motoneuron death occurs between E14.5 and
E18.5 in mice lacking in the ability to produce a func-
tional CNTF receptor complex [5], suggesting that expres-
sion of CNTFR and its relevant ligands is critical between
these timepoints. We therefore studied clc mRNA expres-
sion levels at E16.5. Clc is expressed in muscles along the
whole rostro-caudal axis, at the brachial level (Fig. 1A) as
well as at the lumbar level (Fig. 1E and [8]. It is also
expressed in the tongue (Fig. 1C) like clf (Fig. 1D). The
identity of muscle cells (Fig. 1G) was confirmed by double
staining performed on transgenic mice with the nlacZ
reporter gene under the control of the muscle-specific
MLC promoter [9]. All clc-positive muscle fibers also
stained positive for clf (Fig. 1E, 1F, 1G, 1H and [8]). clc
expression was not detected in certain clf-positive muscles
however, such those around the vibrissae (Fig. 1I and 1J).
Since the level of clc expression is generally low, this could
reflect the limited sensitivity of the in situ hybridization
technique used. To determine the onset of clc and clf
expression in the muscles, the motoneuron targets, we
performed in situ hybridizations at different stages. Clc
and clf are expressed, although at low levels, as soon as the
muscles develop and are clearly observed at E14.5 (Fig. 1K
and 1L).
Clc is also expressed in several organs in which reciprocal
epithelial-mesenchymal interactions are essential, such as
the developing vibrissae (Fig. 1I and 2I), tooth, kidney,
and lung. In the kidney, clc is expressed in the comma-
shaped body (Fig. 2A). Strikingly, CLF and CNTFR are
expressed in different structures, clf being synthesized in
the tips of the ureteric (Fig. 2B) and cntfr being synthe-
sized by mesenchyma cells surrounding these structures
(Fig. 2C). In the lung, both clc and cnftr are expressed
faintly in distal airway epithelium whereas clf is strongly
expressed in distal and proximal epithelia (Fig. 2D, 2E
and 2F). Sections through molar tooth germs (Fig. 2G and
2H) show that clf is expressed in both the mesenchyma
surrounding the dental follicle which gives rise to alveolar
bone and the inner enamel epithelium whereas clc is
expressed only in the former. Clc and clf are also co-
expressed in the epithelium bordering the mandibles and
the lips although clf is also expressed in mesenchyma (Fig.
Table 1: RT-PCR analysis of clc, clf and cntfr expressiona
clc clf cntfr
E16.5 E18.5 E16.5 E18.5 E16.5 E18.5
Skeletal muscle 0.113 ± 0.02 0.936 ± 0.12 0.232 ± 0.003 24.84 ± 2.13 90.25 ± 2.71 6.72 ± 0.76
Heart NSc NS NS NS NS NS
Tongue 3.12 ± 0.12 1.2 ± 0.09 495 ± 17.1 77.1 ± 4.64 28.3 ± 10.9 2.6 ± 0.83
Muzzle 11.4 ± 0.75 9.25 ± 0.79 1050 ± 65.3 524 ± 85.8 425 ± 47.5 57.9 ± 4.02
Lung 4.08 ± 0.65 16.4 ± 0.48 2290 ± 490 2240 ± 184 43.8 ± 15.6 NDb
Kidney 5.55 ± 0.12 6.75 ± 1.15 61.4 ± 4.59 ND 51.8 ± 9.49 19.8 ± 3.12
Liver 0.191 ± 0.02 0.129 ± 0.03 0.071 ± 0.001 0.034 ± 0.09 0.047 ± 0.002 0.038 ± 0.03
Brain 1.04 ± 0.12 0.317 ± 0.09 150 ± 3.39 74.3 ± 16.4 216 ± 2.01 236 ± 16.1
Spinal cord ND 0.183 ± 0.01 0.123 ± 0.01 61.2 ± 6.25 6.13 ± 0.03 109 ± 27.4
aExpression of clc, clf and cntfr was determined using reverse transcription and quantitative real-time PCR as detailed in Experimental Procedures 
and expressed as fM of cDNA/µg total RNA.
bnot determined
cnot significant
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2I and 2J). Together these results are in agreement with
the expression pattern described for both clf [10] and cntfr
[11].
Co-expression of clc, clf and cntfr in the developing 
muscle
In transfected cells CLC requires either CLF or sCNTFR to
be secreted [1,2]. This cooperative effect requires the
expression of genes for both factors in the same cell. To
ascertain whether a single muscle cell can express at least
CLC and CLF or CLC and sCNTFR, we studied co-expres-
sion on hind-limb muscle sections. We performed double
in situ hybridization of clc and clf and of clc and cntfr. Most
muscle cells expressed both clc, (revealed using NBT/
BCIP; Fig. 3A, C) and clf or cntfr (Fig. 3B, D; revealed using
Fast Red). Co-expression was observed at the single cell
level demonstrating that in vivo CLC could be co-secreted
either with CLF or sCNTFR.
Conclusions
Clc is expressed in developing muscles during the period
of motoneuron loss in mice lacking a functional CNTF
receptor and it is co-expressed with both CLF and CNTFR.
This expression pattern is in favor of the hypothesis that
CLC is an important player in the signal triggered by the
CNTF receptor and that is required for motoneuron
development. In addition, our results show that in the
kidney, clc is expressed in cells neighboring those express-
In E16.5 mouse embryos clc is expressed in musclesFigure 1
In E16.5 mouse embryos clc is expressed in muscles. Cryostat sections (A, E-L) or vibratome sections (B-D) from E16.5 
(A-J) or E14.5 (K, L) were hybridized to clc (A, C, E, G, I and K) or clf (D, F, H, J and L). The control clc sense probe gave rise 
to very faint staining (B). Transverse section through the forelimb (A, K and L), the hindlimb (E and F) and saggital sections 
through the tongue (C and D) showing expression of clc and clf in muscles. The identity of the clc-positive cells such as muscle 
fibers was confirmed by double staining and compared to clf-positive cells. In situ hybridization using Dig-labeled probes for clc 
and clf (cytoplasmic blue staining) was performed on sections through shoulder muscles (G, H) or vibrissae (I, J) from E16.5 
MLCnlacZ mice, which express the nlacZ reporter gene under the control of a muscle-specific MLC promoter. Subsequently, 
the sections were processed for immunohistochemical detection of β-galactosidase (nuclear brown staining). Arrows indicate 
double-labeled cells. Transverse section through the muzzle (I and J) shows that vibrissae (arrowheads) are positive for clc and 
clf whereas only clf is detected in muscles (asterisks) surrounding vibrissae. c, cartilage; m, muscle. Scale bars are 200 µm in A, 
E and F, 25 µm in G and H and 100 µm in I-L.
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Clc is expressed in epitheliaFigur  2
Clc is expressed in epithelia Transverse sections from E16.5 mouse embryos were hybridized to clc (A, D, G and I), clf (B, 
E, H and J) or cntfr (C and F). Sections through the kidney (A-C) show that clc is expressed in developing nephrons (arrows), clf 
in ureteric tips (arrowheads) and cntfr in nephrogenic mesenchyme. Sections through the lung (D-F) show that whereas clf is 
strongly expressed in both distal (arrowheads) and proximal (arrows) epithelia, clc and cntfr are weakly expressed in distal epi-
thelium. Boxed areas are shown in higher magnification in the corner of each panel. Sections through molar tooth germs (G, H) 
show that mesenchyma (arrows) surrounding the dental follicle is positive for both clc and clf and that the inner enamel epithe-
lium (arrowheads) expresses only clf. Coronal sections through muzzle (I, J) show that both clc and clf are expressed in the epi-
thelium bordering the mandibles and in between the lips and mandibles (arrow) as well as in follicles of vibrissae (arrowheads); 
in addition, clf is expressed in mesenchyma (asterisks). a, pulmonary artery; dp, dental papilla; de, dental epithelium; oc, oral 
cavity; uli, upper lip; lli, lower lip. Bars: 100 µm in A-H, 200 µm in I and J.
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ing clf or cntfr but it is not co-expressed with these genes
suggesting either the possible existence of an additional
protein capable of inducing secretion of CLC or that CLC
is not secreted in these cells and therefore not functional.
Because genetic deletion of cntf fails to perturb neuronal
development before birth, we can hypothesize some func-
tional redundancies in vivo that will require the analysis of
double or triple knockout mice for CNTFR ligands to clar-
ify their respective involvement in mouse neural
development.
Methods
RT and real time PCR
Total RNA was extracted using Trizol reagent (Invitrogen)
from E16.5 or E18.5 mouse tissues according to the man-
ufacturer's instructions. Complementary cDNA was syn-
thesised from 2 µg of RNA by random hexamer priming
using MMLV reverse transcriptase (Promega). Quantita-
tive PCR was performed using a capillary real-time
LightCycler (Roche Diagnostics), and the data analysed
using "Fit Point Method" (Roche Diagnostics). For com-
parison of gene expression levels, all quantifications were
normalized to endogenous gapdh to account for variabil-
ity in the initial concentration of RNA and for differences
in the efficiency of the reverse transcription reactions. The
following primers were designed to amplify mouse clc: 5'-
GCTACCTGGAGCATCAACT-3', 5'-GGTGACTG-
TACGCCTCATAG-3'; clf: 5'-CAGTCAGGAGACAATCT-
GGT-3', 5'-ACGTGAGATCCTTCATGTTC-3'; cntfr: 5'-
CTACATCCCCAATACCTACA-3', 5'-GTGAATTCGT-
Double-labeling detects co-expression of clc and clf or clc and cntfr in individual muscle cellsFig r  3
Double-labeling detects co-expression of clc and clf or clc and cntfr in individual muscle cells. Single sections of 
E16.5 muscles were hybridized with two probes. Dig-labeled clc (A-D) and Fluo-labeled clf (A, B) or cntfr (C, D). Anti-Dig anti-
bodies were applied first and stained using NBT/BCIP to reveal cells expressing clc (A, C). Anti-Fluo antibodies were then 
applied and detected using Fast red to reveal cells expressing clf (B) and cntfr (D), after removal of the first red reaction prod-
uct. Most muscle cells express clc and clf or clc and cntfr (examples indicated by arrows). Bars: 100 µm.
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CAAAGGTGAT-3'; gapdh: 5'-TGCGACTTCAACAG-
CAACTC-3', 5'-CTTGCTCAGTGTCCTTGCTG-3'. Results
are expressed in fmole of cDNA/µgRNA.
Probes
Plasmid cDNA clones were linearized and transcribed
with T7 or T3 polymerase using digoxigenin (Dig) or flu-
orescein (Fluo)labeling reagents (Roche Diagnostics).
Probes were used at a concentration of 500 ng/ml. The
cntfr clone was as previously described [12] and the
mouse clf [13] and clc probes corresponded to the isolated
cDNAs.
In situ hybridization
In situ hybridization was performed as described previ-
ously [14] on 20 µm-thick frozen transverse cryostat sec-
tions prepared from mouse embryos fixed with 4%
paraformaldehyde in PBS, and cryopreserved in 15%
sucrose in PBS before embedding in OCT compound
(Miles). Alternatively, 100 µm-thick vibratome sections
were prepared from fixed embryos embedded in glutaral-
dehyde/gelatin. After hybridization overnight at 70°C
with Dig-labeled riboprobes, the slides were washed twice
in 1X SSC, 50% formamide at 70°C for 30 min and
blocked in the presence of 4% blocking reagent (Roche
Diagnostics) and 20% inactivated sheep serum. The slides
were then incubated with anti-Dig-alkaline-phosphatase
(AP)-conjugated antibody (1/5000, Roche Diagnostics),
washed and revealed by NBT/BCIP staining.
In order to confirm that muscle fibers, per se, express clc
and clf, double in situ hybridization / immunohistochem-
istry was carried out as described [15] on sections from
E16.5 MLCnlacZ mice, which express the nlacZ reporter
gene under the control of a muscle-specific myosin light
chain promoter. After in situ hybridization, slides were
rinsed in PBT (PBS, 0.1% Triton), and sections were suc-
cessively incubated for 1 h with blocking solution con-
taining 2% BSA, 2% heat-inactivated donkey serum in
PBT and then overnight at 4°C with rabbit anti-β-galac-
tosidasel (1/1000, Cappel). After three washes in PBT,
slides were incubated 1 h at RT with a biotin donkey anti-
mouse secondary antibody. Slides were then washed in
PBS, and TBS (50 mM Tris-HCl, 0.15 M NaCl, pH 7.6),
and incubated for 30 min at RT in ABC streptavidin/HRP
in TBS. Staining was revealed with DAB (D4293, Sigma)
in the presence of H2O2.
Double in situ hybridization was performed as described
previously [14]. Briefly, Dig- and Fluo-labeled probes
were mixed in hybridization buffer and applied to sec-
tions. After hybridization at 70°C overnight and washing
at 65°C, the first probe was revealed using a 1:2000 dilu-
tion of anti-Fluo-alkaline phosphatase (AP)- conjugate
(Roche Diagnostics) and Fast Red (Sigma) as a substrate.
Sections were photographed at this stage. After AP inacti-
vation with 0.1 M glycine, pH 2.2, the second probe was
revealed using a 1:5000 dilution of anti-Dig-AP and NBT/
BCIP staining. Fast Red precipitates were then removed by
incubating the slides in increasing concentrations of etha-
nol culminating in two final incubations in 100% ethanol
for 10 min before cleaning with Histoclear and mounting
with Eukitt (VWR, Strasbourg, France). Photomicrographs
of the NBT/BCIP results were then taken for comparison
with those showing the Fast Red results on the same
sections.
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